THL Partners acquires Celerion Holdings, a global clinical pharmacology CRO, from H.I.G. Capital to expand services and global reach. Read more.
Popular Searches:
Recommended Posts
Search Results
THL Partners acquires Celerion Holdings, a global clinical pharmacology CRO, from H.I.G. Capital to expand services and global reach. Read more.
